Poor penetration of the male genital tract by HIV-1 protease inhibitors

AIDS. 1999 May 7;13(7):859-60. doi: 10.1097/00002030-199905070-00017.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / pharmacokinetics*
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Male
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Ritonavir / pharmacokinetics*
  • Ritonavir / therapeutic use
  • Saquinavir / pharmacokinetics*
  • Saquinavir / therapeutic use
  • Semen / metabolism*
  • Stavudine / therapeutic use

Substances

  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Stavudine
  • Saquinavir
  • Ritonavir